Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy 2 month infants, available for entire study period and parent/legal guardian reachable by telephone~* Able to complete three blood draws during study~* At least 3.5 kg at enrollment~Exclusion Criteria:~* Previous vaccination (except Hepatitis, BCG), contraindication or allergic reaction to vaccines~* Immune deficiency, bleeding disorder or significant chronic medical condition

- Gender: ALL
- Minimum Age: 42 Days
- Maximum Age: 98 Days
- Healthy Volunteers: t

Study Arms:
- A (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).